Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT-2584 in Hormone Refractory Prostate Cancer
NCT00004026Phase 2Terminated
- Sponsor
- CTI BioPharma Corp.
- Start
- Dec 1998
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CT-2584 in prostate cancer (PCa), sponsored by CTI BioPharma Corp.. Started Dec 1998; status: terminated.
02
Drugs
CT-2584
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00004026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004026.